中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共5条，第1-5条

帮助

条数/页：排序方式：
	Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文 OAI收割 THORACIC CANCER, 2022 作者: Wang, Wenxian; Wang, Qian; Xu, Chunwei; Li, Ziming; Song, Zhengbo \| 收藏 \| 浏览/下载：37/0 \| 提交时间：2022/12/23 checkpoint inhibitor pneumonitis Chinese experts consensus immune checkpoint inhibitor-related adverse effects
	Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文 OAI收割 THORACIC CANCER, 2022 作者: Xu, Chunwei; Si, Lu; Wang, Wenxian; Li, Ziming; Song, Zhengbo \| 收藏 \| 浏览/下载：39/0 \| 提交时间：2022/12/22 fusion precision medicine solid tumor targeted therapy tyrosine receptor kinase
	Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文 OAI收割 GENES CHROMOSOMES & CANCER, 2022 作者: Wang, Wenxian; Gu, Xiaodong; Si, Jinfei; Pu, Xingxiang; Wang, Liping \| 收藏 \| 浏览/下载：71/0 \| 提交时间：2022/05/16 BRAF mutation immune checkpoint inhibitors non-small cell lung cancer PD-L1 targeted therapy
	The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文 OAI收割 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者: Wang, Wenxian; Gu, Xiaodong; Wang, Liping; Pu, Xingxiang; Feng, Huijing \| 收藏 \| 浏览/下载：66/0 \| 提交时间：2022/01/10 Non-small cell lung cancer PD-L1 Immune checkpoint inhibitor Immune-related adverse event
	Prevalence and clinical significance of pathogenic germline BRCA1 2 mutations in Chinese non-small cell lung cancer patients 期刊论文 OAI收割 Cancer Biology & Medicine, 2019, 卷号: 16 作者: Hu Xingsheng; Yang Dongyong; Li Yalun; Li Li; Wang Yan \| 收藏 \| 浏览/下载：34/0 \| 提交时间：2020/12/28 SUSCEPTIBILITY LOCUS PROSTATE-CANCER OVARIAN-CANCER BREAST RISK MULTICENTER EXPRESSION INHIBITORS VARIANTS CARRIERS Germline BRCA mutations non-small cell lung cancer prevalence BRCA1 BRCA2